Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma

Background: Malignant pleural effusion (MPE) comes generally with high mortality and poor prognosis. Recurrence of symptomatic MPE is always accompanied by survival quality. In lung adenocarcinoma, researchers speculate whether patients actionable mutation or without are applicable to different management models for MPE. Under the background probability encouraging therapeutic response in Asians, researches on risk factors need.